Olivier Hermine

Research interests

Publications

• Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2201817

• Genomic profiling for clinical decision making in lymphoid neoplasms

  Blood · 2022 · https://doi.org/10.1182/blood.2022015854

• Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

  The Journal of Experimental Medicine · 2021 · https://doi.org/10.1084/jem.20210554

• Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

  The Lancet Respiratory Medicine · 2021 · https://doi.org/10.1016/s2213-2600(20)30556-7

• Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

  JAMA Internal Medicine · 2020 · https://doi.org/10.1001/jamainternmed.2020.6820

• Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19

  Blood · 2020 · https://doi.org/10.1182/blood.2020008423

• International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

  The Lancet Haematology · 2019 · https://doi.org/10.1016/s2352-3026(19)30166-8

• Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1705342

• Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx223

• Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

  Journal of Allergy and Clinical Immunology · 2017 · https://doi.org/10.1016/j.jaci.2016.12.978

• Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis

  Journal of Neuroinflammation · 2016 · https://doi.org/10.1186/s12974-016-0620-9

• Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.63.8387

• Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)00739-x

• Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

  Journal of Allergy and Clinical Immunology · 2015 · https://doi.org/10.1016/j.jaci.2015.08.034

• Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation

  Blood · 2014 · https://doi.org/10.1182/blood-2013-12-543793

• Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2014.55.2018

• Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.52.2466

• ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

  Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mds643

• Treatment of Older Patients with Mantle-Cell Lymphoma

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1200920

• ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

  Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds517

• Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

  Blood · 2009 · https://doi.org/10.1182/blood-2009-06-230250

• Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

  The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)61302-7

• Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

  European Journal of Clinical Investigation · 2007 · https://doi.org/10.1111/j.1365-2362.2007.01807.x

• High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

  New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa070484

• Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection

  New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa013376

• CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans

  Proceedings of the National Academy of Sciences · 2001 · https://doi.org/10.1073/pnas.98.3.1166

Current projects

No projects listed.